Education
About Us
Working with TipRanks
Follow Us
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Neuphoria Therapeutics. The associated price target remains the same with $35.00. Jason McCarthy has given his Buy rating
...Read more
NEUP News on the Web
rttnews
Neutral
Yahoo Finance
Neutral
Zacks
Bullish
TipRanks News
Neutral
TipRanks News
Neutral
Yahoo Finance
Neutral
Yahoo Finance
Neutral
Yahoo Finance
Neutral
News Score - Last 7 Days
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is NEUP’s Media Buzz Sentiment?
Currently, no data Available
What is NEUP’s weekly average amount of articles?
Currently, no data Available
What is NEUP’s News Sentiment?
59% of articles about NEUP were positive this week, compared to its sector average of 55%.